IDEAYA Biosciences, Inc.
IDYA · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $84 | $157 | $69 | $92 |
| Short-Term Investments | $592 | $368 | $296 | $155 |
| Receivables | $0 | $0 | $0 | $1 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $13 | $8 | $5 | $3 |
| Total Curr. Assets | $690 | $533 | $370 | $251 |
| Property Plant & Equip (Net) | $28 | $8 | $9 | $9 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $406 | $107 | $8 | $121 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $1 | $1 | $0 | $0 |
| Total NC Assets | $434 | $117 | $18 | $130 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $1,124 | $649 | $388 | $381 |
| Liabilities | – | – | – | – |
| Payables | $15 | $7 | $4 | $2 |
| Short-Term Debt | $0 | $2 | $2 | $2 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $9 | $29 |
| Other Curr. Liab. | $30 | $19 | $17 | $12 |
| Total Curr. Liab. | $46 | $27 | $32 | $45 |
| LT Debt | $19 | $1 | $2 | $3 |
| Deferred Rev, NC | $0 | $0 | $5 | $31 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $0 | $0 | $0 |
| Total NC Liab. | $19 | $1 | $7 | $35 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $19 | $3 | $3 | $5 |
| Total Liabilities | $65 | $28 | $39 | $80 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$623 | -$348 | -$235 | -$177 |
| AOCI | $1 | $1 | -$3 | -$1 |
| Other Equity | $1,681 | $969 | $588 | $479 |
| Total Equity | $1,059 | $621 | $349 | $302 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $1,124 | $649 | $388 | $381 |
| Net Debt | -$65 | -$154 | -$65 | -$87 |